Literature DB >> 25469238

Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK.

Noriko Yokoyama1, W Todd Miller1.   

Abstract

Anaplastic lymphoma kinase (ALK) is a member of the receptor tyrosine kinase superfamily. The ALK gene is a site of frequent mutation and chromosomal rearrangement in various types of human cancers. A novel chromosomal translocation was recently identified in human colorectal cancer between the ALK gene and chromosome 2, open reading frame 44 (C2orf44), a gene of unknown function. As a first step in understanding the oncogenic properties of this fusion protein, C2orf44 cDNA was cloned and the encoded protein was characterized, which was designated as WD repeat and coiled coil containing protein (WDCP). A C-terminal proline-rich segment in WDCP was shown to mediate binding to the Src homology 3 domain of the Src family kinase hematopoietic cell kinase (Hck). Co-expression with Hck lead to tyrosine phosphorylation of WDCP. Chromatographic fractionation of WDCP-containing lysates indicates that the protein exists as an oligomer in mammalian cells. These results suggest that, in the context of the ALK-C2orf44 gene fusion, WDCP imposes an oligomeric structure on ALK that results in constitutive kinase activation and signaling.

Entities:  

Keywords:  Src homology 3 domain; anaplastic lymphoma kinase; chromosomal translocation; hematopoietic cell kinase

Year:  2014        PMID: 25469238      PMCID: PMC4251150          DOI: 10.3892/br.2014.374

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  19 in total

1.  Improving SH3 domain ligand selectivity using a non-natural scaffold.

Authors:  J T Nguyen; M Porter; M Amoui; W T Miller; R N Zuckermann; W A Lim
Journal:  Chem Biol       Date:  2000-07

Review 2.  The WD repeat: a common architecture for diverse functions.

Authors:  T F Smith; C Gaitatzes; K Saxena; E J Neer
Journal:  Trends Biochem Sci       Date:  1999-05       Impact factor: 13.807

3.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

4.  Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity.

Authors:  Daniel Cussac; Catherine Greenland; Serge Roche; Ren-Yuan Bai; Justus Duyster; Stephan W Morris; Georges Delsol; Michèle Allouche; Bernard Payrastre
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

5.  Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications.

Authors:  James G Bilsland; Alan Wheeldon; Andrew Mead; Petr Znamenskiy; Sarah Almond; Kerry A Waters; Matthew Thakur; Vahri Beaumont; Timothy P Bonnert; Robert Heavens; Paul Whiting; George McAllister; Ignacio Munoz-Sanjuan
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

Review 6.  The anaplastic lymphoma kinase in the pathogenesis of cancer.

Authors:  Roberto Chiarle; Claudia Voena; Chiara Ambrogio; Roberto Piva; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

7.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

8.  A mouse model for EML4-ALK-positive lung cancer.

Authors:  Manabu Soda; Shuji Takada; Kengo Takeuchi; Young Lim Choi; Munehiro Enomoto; Toshihide Ueno; Hidenori Haruta; Toru Hamada; Yoshihiro Yamashita; Yuichi Ishikawa; Yukihiko Sugiyama; Hiroyuki Mano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors:  Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

View more
  3 in total

1.  Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.

Authors:  Jeeyun Lee; Hee Cheol Kim; Jung Yong Hong; Kai Wang; Sun Young Kim; Jiryeon Jang; Seung Tae Kim; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Young Suk Park; Jiyun Lee; Woo Yong Lee; Yoon Ah Park; Jung Wook Huh; Seong Hyeon Yun; In-Gu Do; Seok Hyung Kim; Sohail Balasubramanian; Philip J Stephens; Jeffrey S Ross; Gang Gary Li; Zachary Hornby; Siraj M Ali; Vincent A Miller; Kyoung-Mee Kim; Sai-Hong Ignatius Ou
Journal:  Oncotarget       Date:  2015-09-15

2.  Insufficient antibody validation challenges oestrogen receptor beta research.

Authors:  Sandra Andersson; Mårten Sundberg; Nusa Pristovsek; Ahmed Ibrahim; Philip Jonsson; Borbala Katona; Carl-Magnus Clausson; Agata Zieba; Margareta Ramström; Ola Söderberg; Cecilia Williams; Anna Asplund
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919

3.  ALK alteration is a frequent event in aggressive breast cancers.

Authors:  Abdul K Siraj; Shaham Beg; Zeenath Jehan; Sarita Prabhakaran; Maqbool Ahmed; Azhar R Hussain; Fouad Al-Dayel; Asma Tulbah; Dahish Ajarim; Khawla S Al-Kuraya
Journal:  Breast Cancer Res       Date:  2015-09-17       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.